A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers

Clinical trial NCT05069623 · COMPLETED

Trial details

NCT number: NCT05069623
Sponsor: Nykode Therapeutics ASA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Infection Viral Infections

Start date: 2021-11-01
Primary completion: 2022-12-16
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.